Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border

<p>Abstract</p> <p>Background</p> <p>The region situated where the borders of Mexico, Texas and New Mexico meet is known as 'Paso del Norte'. The Paso del Norte Collaborative was formed to study the seroprevalence of select pathogens and associated risk behavi...

Full description

Bibliographic Details
Main Authors: Arbona Sonia, Cruz Michelle, Mueller Mark, Foster Lily N, Baumbach Joan P, Melville Sharon, Ramos Rebeca, Strathdee Steffanie A
Format: Article
Language:English
Published: BMC 2008-11-01
Series:Harm Reduction Journal
Online Access:http://www.harmreductionjournal.com/content/5/1/33
id doaj-485585a2112441b984e1335c86e4c89d
record_format Article
spelling doaj-485585a2112441b984e1335c86e4c89d2020-11-24T23:58:13ZengBMCHarm Reduction Journal1477-75172008-11-01513310.1186/1477-7517-5-33Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico borderArbona SoniaCruz MichelleMueller MarkFoster Lily NBaumbach Joan PMelville SharonRamos RebecaStrathdee Steffanie A<p>Abstract</p> <p>Background</p> <p>The region situated where the borders of Mexico, Texas and New Mexico meet is known as 'Paso del Norte'. The Paso del Norte Collaborative was formed to study the seroprevalence of select pathogens and associated risk behaviors among injection drug users (IDUs) in the region.</p> <p>Methods</p> <p>Respondent-driven sampling (RDS) was used: 459 IDU participants included 204 from Mexico; 155 from Texas; and 100 from New Mexico. Each of the three sites used a standardized questionnaire that was verbally administered and testing was performed for select bloodborne infections.</p> <p>Results</p> <p>Participants were mostly male (87.4%) and Hispanic/Latino (84.7%) whose median age was 38. In Mexico, Texas and New Mexico, respectively: hepatitis B virus (HBV) was seen in 88.3%, 48.6% and 59.6% of participants; hepatitis C virus (HCV) in 98.7%, 76.4% and 80.0%; human immunodeficiency virus (HIV) in 2.1%, 10.0% and 1.0%; and syphilis in 4.0%, 9.9% and 3.0%. Heroin was the drug injected most often. More IDUs in New Mexico were aware of and used needle exchange programs compared with Texas and Mexico.</p> <p>Conclusion</p> <p>There was mixed success using RDS: it was more successfully applied after establishing good working relationships with IDU populations. Study findings included similarities and distinctions between the three sites that will be used to inform prevention interventions.</p> http://www.harmreductionjournal.com/content/5/1/33
collection DOAJ
language English
format Article
sources DOAJ
author Arbona Sonia
Cruz Michelle
Mueller Mark
Foster Lily N
Baumbach Joan P
Melville Sharon
Ramos Rebeca
Strathdee Steffanie A
spellingShingle Arbona Sonia
Cruz Michelle
Mueller Mark
Foster Lily N
Baumbach Joan P
Melville Sharon
Ramos Rebeca
Strathdee Steffanie A
Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border
Harm Reduction Journal
author_facet Arbona Sonia
Cruz Michelle
Mueller Mark
Foster Lily N
Baumbach Joan P
Melville Sharon
Ramos Rebeca
Strathdee Steffanie A
author_sort Arbona Sonia
title Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border
title_short Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border
title_full Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border
title_fullStr Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border
title_full_unstemmed Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border
title_sort seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the paso del norte region of the united states – mexico border
publisher BMC
series Harm Reduction Journal
issn 1477-7517
publishDate 2008-11-01
description <p>Abstract</p> <p>Background</p> <p>The region situated where the borders of Mexico, Texas and New Mexico meet is known as 'Paso del Norte'. The Paso del Norte Collaborative was formed to study the seroprevalence of select pathogens and associated risk behaviors among injection drug users (IDUs) in the region.</p> <p>Methods</p> <p>Respondent-driven sampling (RDS) was used: 459 IDU participants included 204 from Mexico; 155 from Texas; and 100 from New Mexico. Each of the three sites used a standardized questionnaire that was verbally administered and testing was performed for select bloodborne infections.</p> <p>Results</p> <p>Participants were mostly male (87.4%) and Hispanic/Latino (84.7%) whose median age was 38. In Mexico, Texas and New Mexico, respectively: hepatitis B virus (HBV) was seen in 88.3%, 48.6% and 59.6% of participants; hepatitis C virus (HCV) in 98.7%, 76.4% and 80.0%; human immunodeficiency virus (HIV) in 2.1%, 10.0% and 1.0%; and syphilis in 4.0%, 9.9% and 3.0%. Heroin was the drug injected most often. More IDUs in New Mexico were aware of and used needle exchange programs compared with Texas and Mexico.</p> <p>Conclusion</p> <p>There was mixed success using RDS: it was more successfully applied after establishing good working relationships with IDU populations. Study findings included similarities and distinctions between the three sites that will be used to inform prevention interventions.</p>
url http://www.harmreductionjournal.com/content/5/1/33
work_keys_str_mv AT arbonasonia seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder
AT cruzmichelle seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder
AT muellermark seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder
AT fosterlilyn seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder
AT baumbachjoanp seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder
AT melvillesharon seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder
AT ramosrebeca seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder
AT strathdeesteffaniea seroprevalenceofselectbloodbornepathogensandassociatedriskbehaviorsamonginjectiondrugusersinthepasodelnorteregionoftheunitedstatesmexicoborder
_version_ 1725451133480075264